Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growth
Xiao Lei Chen(Xiamen University), David D. Schlaepfer(UC San Diego Health System), Christine Jean(Centre National de la Recherche Scientifique), Antonia Boyer(University of California San Diego), Marjaana Ojalill(University of Turku), Joseph Schlessinger(Yale University), Duygu Ozmadenci(University of California San Diego), Sean Uryu(Pfizer (United States)), Isabelle Tancioni(University of California San Diego), Dwayne G. Stupack(Scripps Research Institute), Shulin Jiang(Johns Hopkins University)
Cited by 5
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation.
|The EMBO Journal|1992|1k
Differential regulation of cell motility and invasion by FAK
|The Journal of Cell Biology|2003|530
Fibronectin-Stimulated Signaling from a Focal Adhesion Kinase–c-Src Complex: Involvement of the Grb2, p130 <sup> <i>cas</i> </sup> , and Nck Adaptor Proteins
|Molecular and Cellular Biology|1997|432